US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
FA

FAE.MC

Stock Faes Farma, S.A.
$4.46

Bolsa de Madrid · Healthcare · ES

Sharia status
NOT COMPLIANT
Per In-house ratio engine · assessed 2026-08-27
HTR non-permissible income 0.37%
🕌Open research, not a fatwa — verify with your own scholar.
Trade setup SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

Faes Farma, S.A. (FAE.MC) is currently considered not halal (non-compliant), per In-house ratio engine (last assessed 2026-08-27). See the full ratio breakdown and business-activity screen below for the reasoning.

⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.

Market & analysts
Price target
$5.36
+20.2% · 4 analysts
Institutional own.
15.7%
of shares
NON-COMPLIANT
Sharia compliance
0.37%
Non-permissible income — HTR, from filings (2025-12-31)
$5.36
Price target (+20.2%) · 4 analysts
15.7%
Institutional ownership

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2025-12-31. FAE.MC files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.

Business activity: cleared (no excluded categories detected)

AAOIFI Fail

RatioValueThresholdResult
Interest-bearing debt 30.61% 30.00% Fail
Interest-bearing investments 9.36% 30.00% Pass
Non-permissible income 0.37% 5.00% Pass

Usmani Pass

RatioValueThresholdResult
Interest-bearing debt 32.42% 33.00% Pass
Interest-bearing investments 9.69% 33.00% Pass
Non-liquid assets 82.75% at least 20.00% Pass
Non-permissible income 0.37% 5.00% Pass

MSCI Pass

RatioValueThresholdResult
Interest-bearing debt 31.71% 33.33% Pass
Cash + interest-bearing securities 9.69% 33.33% Pass
Accounts receivable 17.25% 33.33% Pass
Non-permissible income 0.37% 5.00% Pass

FTSE Pass

RatioValueThresholdResult
Interest-bearing debt 31.71% 33.33% Pass
Cash + interest-bearing securities 9.69% 33.33% Pass
Accounts receivable 17.25% 50.00% Pass
Non-permissible income 0.37% 5.00% Pass

Dow Jones Islamic Market Pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 32.88% 33.00% Pass
Cash + interest-bearing securities 10.05% 33.00% Pass
Accounts receivable 7.83% 33.00% Pass
Non-permissible income 0.37% 5.00% Pass

S&P Shariah Fail

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 36.19% 33.00% Fail
Cash + interest-bearing securities 11.06% 49.00% Pass
Accounts receivable 8.62% 49.00% Pass
Non-permissible income 0.37% 5.00% Pass

MSCI M-Series Fail

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 36.19% 33.33% Fail
Cash + interest-bearing securities 11.06% 33.33% Pass
Accounts receivable 19.68% 49.00% Pass
Non-permissible income 0.37% 5.00% Pass

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

5.244.944.644.344.042025-09-122026-03-132026-09-11

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
4.38
S2
4.41
S1
4.43
PIVOT
4.46
R1
4.48
R2
4.51
R3
4.53

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

7-day expected range
4.29 4.63
±3.73% from 4.46, made 2026-09-10 · resolves 2026-09-17
STRONG SELL
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 22583 forecast(s) are currently open and will be scored automatically when their horizon expires.

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

Technical Summary

STRONG SELL
19 indicators
OscillatorsSTRONG SELL
1 buy · 3 neutral · 3 sell
Moving averagesSTRONG SELL
0 buy · 0 neutral · 12 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)43.30NEUTRAL
Stochastic %K (14)21.62NEUTRAL
CCI (20)-114.62BUY
Williams %R (14)-78.38NEUTRAL
MACD (12,26,9)-0.01SELL
ROC (10)-2.52SELL
Momentum (10)-0.12SELL
EMA (10)4.49SELL
SMA (10)4.49SELL
EMA (20)4.50SELL
SMA (20)4.51SELL
EMA (30)4.51SELL
SMA (30)4.52SELL
EMA (50)4.52SELL
SMA (50)4.51SELL
EMA (100)4.54SELL
SMA (100)4.54SELL
EMA (200)4.58SELL
SMA (200)4.69SELL

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

About Faes Farma, S.A.

Healthcare · Drug Manufacturers - Specialty & Generic

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants services, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. The company also provides animal nutrition and health products. It offers products for various therapeutic areas. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.

faesfarma.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

🕌 In-house Ratio Research — filings.xbrl.org ESEF XBRL

Research only, not the primary verdict above — SEC EDGAR (the source for the main in-house research card, if shown) has no data for this symbol, so this is computed from a real, country-specific filing instead. Business-activity screening isn't part of this check.

AAOIFI Standard 21 (% of market cap) — Unverified
Debt ratio no data
Investments ratio 4.6% (< 30%)
Non permissible income ratio no data
Usmani (% of total assets) — Unverified
Debt ratio no data
Investments ratio 7.5% (< 33%)
Nonliquid assets ratio 78.5% (< 20%)
Non permissible income ratio no data
Net liquid assets $0.1B (mkt cap $1.4B)

Based on the filing period ending 2024-12-31, figures in EUR.

SMC — Top Down

Not enough price history yet for a smart-money structure read on any timeframe.

Momentum & Volume

Peer Movement

Peer movement computing — it will appear here on its own.

Insider Activity (90d)

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

NEUTRAL   report date 2026-09-08 · Asset managers net 912361 (-21819)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.